Turkish Journal of Medical Sciences
Volume 49

Number 3

Article 14

1-1-2019

Investigation of treatment efficacy of 10% povidone-iodine
sclerotherapy on ovarian cyst diameter: an experimental study
REMZİ ATILGAN
ŞEHMUS PALA
TUNCAY KULOĞLU

Follow this and additional works at: https://journals.tubitak.gov.tr/medical
Part of the Medical Sciences Commons

Recommended Citation
ATILGAN, REMZİ; PALA, ŞEHMUS; and KULOĞLU, TUNCAY (2019) "Investigation of treatment efficacy of
10% povidone-iodine sclerotherapy on ovarian cyst diameter: an experimental study," Turkish Journal of
Medical Sciences: Vol. 49: No. 3, Article 14. https://doi.org/10.3906/sag-1810-27
Available at: https://journals.tubitak.gov.tr/medical/vol49/iss3/14

This Article is brought to you for free and open access by TÜBİTAK Academic Journals. It has been accepted for
inclusion in Turkish Journal of Medical Sciences by an authorized editor of TÜBİTAK Academic Journals. For more
information, please contact academic.publications@tubitak.gov.tr.

Turkish Journal of Medical Sciences

Turk J Med Sci
(2019) 49: 795-801
© TÜBİTAK
doi:10.3906/sag-1810-27

http://journals.tubitak.gov.tr/medical/

Research Article

Investigation of treatment efficacy of 10% povidone–iodine sclerotherapy on ovarian cyst
diameter: an experimental study
1,

1

2

Remzi ATILGAN *, Şehmus PALA , Tuncay KULOĞLU 
Department of Obstetrics and Gynecology, School of Medicine, Fırat University, Elazığ, Turkey
2
Department of Histology and Embryology, School of Medicine, Fırat University, Elazığ, Turkey

1

Received: 03.10.2018

Accepted/Published Online: 16.03.2019

Final Version: 18.06.2019

Background/aim: The purpose of this study was to investigate the effects of 10% povidone–iodine (PI) sclerotherapy on ovarian cyst
diameter through an experimental study.
Materials and methods: To be able to create ovarian cysts, right unilateral salpingectomy was performed on 20 Wistar albino rats. One
month after the operation, the abdomens of all rats were reopened. Sixteen rats with macroscopic ovarian cysts were divided randomly
into 2 groups consisting of 8 rats. Group 1 (G1): the cyst content was only aspirated. Group 2 (G2): the ovarian cyst was aspirated and
then the cystic cavity was irrigated with PI. Abdomens of all rats were closed and 1 month later they were reopened. Tissues of the right
ovaries of the rats were embedded in paraffin blocks for histopathological examination. Follicle count, fibrosis, and congestion were
evaluated under a light microscope.
Results: For G1, there was no difference in cyst diameters before and after aspiration. In G2, a decrease was observed in cyst diameter.
There was no difference in ovarian reserve between the 2 groups. When compared with G1, an increase in fibrosis and congestion was
determined in G2.
Conclusions: Sclerotherapy into the ovarian cyst for a 5-min period using 10% PI reduces cyst diameter without any change in ovarian
reserve.
Key words: Povidone–iodine, cysts, ovarian reserve, rat

1. Introduction
Ovarian cysts are common, affecting 20% of women
at some point in their lives (1). Unlike unilocular cysts
including septations, solid irregular wall, or internal
plaques, the simple ovarian cyst is defined as an anechoic
round or oval lesion (2). The maximum diameter of simple
ovarian cysts in premenopausal women is less than 5 cm;
they often disappear during the menstrual cycle and do
not require further intervention. Larger cysts (5–7 cm)
should be followed using ultrasonography. Cysts larger
than 7 cm may require advanced imaging or surgery (3). In
the treatment protocols for benign ovarian cysts, methods
such as medical treatment (especially oral contraceptives),
ultrasound-guided aspiration, laparoscopy (cystectomy
or ablation of drainage and cystic wall), and laparotomy
(cystectomy) are used (4,5).
Sclerotherapy can be used for women who have
ovarian cysts but want to protect their fertility and do
not want surgical treatment (6). It has been reported

that sclerotherapy has many advantages such as minimal
trauma, lower surgical risks and complications, low cost,
and reduced recurrence rates (7,8). USG-guided aspiration
and sclerotherapy have been reported as a low-cost and
effective treatment for benign cysts localized in other
organs such as the thyroid, parathyroid, liver, kidney, and
spleen (9).
Tetracycline, methotrexate, and ethanol are the most
common agents used for sclerotherapy. When compared
to women without cysts, sclerotherapy applied to infertile
women with ovarian cysts has been shown to reduce
pelvic pain without affecting the number of follicles, term
pregnancy and abortion rates, the number of obtained
oocytes, embryo quality, or hormonal levels (10–13).
Compared to other sclerosing agents, povidone–iodine
(PI) is a less toxic, less irritating, economical, and readily
available agent. In addition to local antiseptic, antibacterial,
and antifungal effects, it has a sclerotherapeutic effect, and
preparation of it at the desired concentration is easy (14).
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A 10% PI solution contains 1% available iodine, but the
free iodine is at 0.1% concentration (15). In a systematic
review, it was reported that iodine had no harmful effect
on thyroid function and had no important side effects in
terms of allergic reactions with iodine or cytotoxicity (16).
However, in one study, it was shown that PI had a direct
cytotoxic effect and stimulated necrosis in tissue (17).
Sclerotherapy with PI is suggested as an effective, safe, and
reproducible treatment method for symptomatic renal
cysts (18) and peritoneal inclusion cysts (19).
In this experimental study, it was aimed to investigate
the effect of 10% PI instillation for 5 min on cyst diameter
and ovarian reserve in ovarian cysts by taking advantage of
its cytotoxic and tissue necrosis effects.
2. Materials and methods
This study was approved by Fırat University Animal Use
Committee and conducted at Fırat University Animal
Laboratory (Date: 2017/04; number of ethic committee
approval: 50). Twenty mature, 12–14-week-old female
Wistar albino rats having regular cycles and weighing
190–220 g were used in this study. Rats were kept under
light and dark cycles for 12 h (from 07:00 to 19:00) at a
room temperature of 21–23 °C in groups of 5 per cage as
compatible to their biological rhythms. Standard pellets and
tap water were used for feeding and watering the animals.
Before the surgical interventions, oral feeding except water
intake was stopped. Rats at the estrous stage of the cycle as
documented by vaginal cytology were anesthetized using
70 mg/kg intramuscular ketamine (Ketalar, Eczacıbası,
Turkey) and 10 mg/kg xylazine (Rompun, Bayer, Turkey).
Surgical site antisepsis was achieved by using 10% PI.
After midline laparotomy, right total salpingectomy was
performed for induction of ovarian cysts as described by
Atilgan et al. (20), and then the abdomen was closed with
3/0 silk sutures. One month after the first surgery, a second
laparotomy was performed and macroscopic ovarian cysts
were observed in 16 rats (80%) (Figure 1). Four rats in
which macroscopic cysts were not observed were excluded
from the study. The remaining 16 rats with macroscopic
ovarian cysts were randomly divided into 2 groups:
Group 1 (n = 8): the ovarian cyst was aspirated with
an insulin injector and then the abdomen was closed
(Figure 2).
Group 2 (n = 8): the ovarian cyst was aspirated with an
insulin injector (Figure 2) and then the cystic cavity was
irrigated with 10% PI at half of the aspirated cyst volume.
Five minutes later, the 10% PI was reaspirated and the
abdomen was closed.
One month after the second laparotomy, 16 rats were
decapitated just after the administration of intraperitoneal
ketamine (75 mg/kg) + xylazine (10 mg/kg) and the
laparotomy was performed. The presence and diameter

796

Figure 1. Ovarian cyst before aspiration.

Figure 2. Ovarian cyst aspiration by insulin syringe.

of the ovarian cysts were recorded again for each rat,
and right oophorectomy was then carried out for
histological evaluations. Ovarian tissues were fixed in 10%
formaldehyde and embedded in paraffin blocks; 4–6 µm
sections were obtained from these blocks and stained with
Masson’s trichrome to be able to determine ovarian follicle
reserve, fibrosis, and congestion. Olympus BX50 light
microscopy (Olympus Corporation, Tokyo, Japan) was
used to determine and photograph the sections. Fibrosis
score was determined as follows: 0 = none, +1 = mild, +2
= moderate, +3 = intense. The congestion in ovarian tissue
was scored on a scale ranging from 0 to 3 (0: none; 1: mild;
2: moderate; 3: severe) (20). For follicular development,
the method of Mazaud et al. (21) was used in microscopic
classification. In the light microscopic examination
of ovarian sections belonging to all groups, follicle
classification was performed according to the following
characteristics. Primordial follicle: oocyte is partially or
completely surrounded by granulosa cells. Primary follicle:
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the follicle in which a single cubic granulosa cell layer is
observed around the oocyte follicle. Antral (secondary)
follicle: the follicle where the oocyte is covered with more
than 2 layers of granulosa cells and where the formation
of the antrum begins. Tertiary (Graafian) follicle: the
follicle possesses a single large space (antrum) in which a
decreasing number of granulosa cells surround an antrum
full of follicular fluid, and that oocyte is surrounded by
some granulosa cells (cumulus cells).
2.1. Statistical analysis
For statistical analysis, SPSS version 22.0 (IBM Corporation,
Armonk, NY, USA) software was used. Comparison of
groups was carried out by using the Mann–Whitney U
test, and the repetitive comparisons were done with the
Wilcoxon rank test. P < 0.05 was considered statistically
significant.
3. Results
3.1. Macroscopic findings
When ovarian cyst size was evaluated in G1, there were
no significant differences in terms of cyst diameters before
(12.5 [7–14] mm) and after the aspiration (13 [9–16] mm)
(P = 0.206). In G2, there was a statistically significant
difference in cyst diameters before (11.5 [9–16] mm) and
after the 10% PI administration (5.5 [0–15] mm), (P =
0.017) (Figure 3, Table 1).
3.2. Histological findings
The results of the examination of the ovarian tissue, which
was stained with Masson’s trichrome, under the light
microscope were as follows.

3.3. Congestion
When G1 (Figure 4a) was compared with G2 (Figure 4b),
there was a statistically significant increase in congestion
(black arrow) in G2 (P < 0.05) (Table 2).
3.4. Fibrosis
When G1 (Figure 4a) was compared with G2 (Figure 4b),
there was a statistically significant increase in fibrosis in
the cyst-adjacent area (red star) and parenchyma (black
star) in G2 (P < 0.05) (Table 2).
3.5. Ovarian reserve
Comparing G1 and G2, there was no significant
difference between the 2 groups in terms of the number
of primordial (10.25 ± 2.31 / 9.25 ± 1.76), primary (9.37 ±
3.24 / 8.62 ± 2.61), secondary (4.25 ± 1.03 / 3.87 ± 0.64),
and tertiary follicles (0.50 ± 0.53 / 0.37 ± 0.51), and the
number of corpora lutea (11.50 ± 1.60 / 10.87 ± 2.10) (P
> 0.05) (Figures 4a and 4b, Table 3).
4. Discussion
The management of benign ovarian cysts is important
in protecting fertility during the reproductive period.
High recurrence rates in aspiration treatments have
led researchers to treat these cysts by applying various
sclerosing agents. In our study, we showed that 10% PI
applied to simple ovarian cysts for 5 min reduced the
cyst size significantly according to the aspiration-only
application by increasing the congestion in the ovarian
tissue and the fibrosis in the parenchyma tissue adjacent
to the cyst. During the literature review in PubMed,
no study on the administration of PI to ovarian cysts

Figure 3. Cyst diameters before and after 10% PI administration (mm). Values are given as mean ± standard deviation. a = When
compared with before 10% PI administration (P < 0.05).
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Table 1. Cyst diameters in both groups before and after application.
Rat’s number

Cyst diameters before
aspiration (mm)

Cyst diameters after
aspiration (mm)

Cyst diameters before PI
administration (mm)

Cyst diameters after PI
administration (mm)

1

14

12

13

8

2

15

13

16

5

3

13

14

11

3

4

11

10

12

15

5

19

13

13

6

6

6

5

9

5

7

5

3

13

0

8

12

11

14

6

Mean values

11.8 ± 4.6

10.1 ± 4.0

12.6 ± 2.0

6.0 ± 4.3a

Values are given as mean ± standard deviation.
a
When compared to before PI instillation group (P < 0.05).

Figure 4. CL: corpus luteum, GF: graft follicle, SF: secondary follicle. Black arrow: congestion, red star: fibrosis near the cyst, black star:
shows fibrosis in the tissue far away from the cyst.

was identified. Therefore, it can be said that this study is
original.
Transvaginal aspiration of ovarian cysts has many
advantages, such as excellent tolerability, low risk and cost,
and low complication and recurrence rates. Therefore, it
has been reported that cyst aspiration may be a reliable
alternative to surgery (8,22–24). However, when the studies
in the literature are examined, it is observed that aspirationonly models have higher recurrence rates than aspiration
models using a sclerotherapeutic agent. Koutlaki et al. (22)
reported that the transvaginal aspiration-only operation on
simple ovarian cysts larger than 4 cm had a recurrence rate
between 48% and 59%, depending on the patient groups.
In another study, it was emphasized that the aspiration of
simple ovarian cysts with transvaginal needle was safe. In the
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follow-up carried out for 1–6 months, the recurrence rate
was reported as 39% in ovarian cysts. In the same study, the
recurrence rate was reported as 62% in endometriomas, 35%
in serous cysts, and 15% in serous–hemorrhagic cysts (8). It
has been reported that sclerotherapy of simple ovarian cysts
with ethanol without anesthesia in the office environment
is an applicable technique with low complication and
recurrence rates (23). At the end of a 12-month follow-up
after the operation, Kars et al. (24) showed that transvaginal
aspiration-only applied to nonneoplastic ovarian cysts had
a recurrence rate of 50% and tetracycline sclerotherapy
applied together with transvaginal aspiration had a
recurrence rate of 14%. As in the literature, we did not find
any significant reduction in cyst diameter in Group 1 at the
end of this experimental study.
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Table 2. Histological score for fibrosis and congestion histoscore
in both groups.
Groups

Fibrosis

Congestion

After aspiration

1.25 ± 1.03

0.87 ± 0.83

After 10% PI administration

2.62 ± 0.51

2.25 ± 0.8a

a

Values are given as mean ± standard deviation.
a
When compared to the postaspiration group (P < 0.05).

It has been indicated that ethanol sclerotherapy, one
of the medical treatment methods for cysts, has some
complications such as intestinal perforation, intestinal
stricture, neoplastic cells spreading to the peritoneal cavity,
extensive pelvic adhesions, and pelvic bacterial infections
(25). Due to the possible complications of the ethanol in
cyst sclerotherapy, the efficacy of PI in sclerotherapy of
ovarian cysts, which has antibacterial effects and is welltolerated but not toxic or irritant, was investigated in this
study (26).
It was shown that PI had success as a sclerosing agent
in spaces with surrounded inline epithelium in recurrent
fluid accumulation cases (26). It is reported that PI is a
safe and effective sclerosing agent in lymphocele, pleural
effusion, empyema, pericardial effusion, thyroid cysts,
hydrocele, and lung Echinococcosis (26–28). PI was first
used as a sclerotherapy agent by Teruel et al. (29). In that
study, PI was instilled into the lymphocele via percutaneous
catheters and the researchers found significant decreases
in lymphocele diameters. Damianao et al. (30) aspirated
about 300 ± 50 mL of lymphocele fluid with double-lumen
catheters from 6 patients in whom lymphoceles developed
after renal transplantation; they instilled 10 mL 5% PI in
the recurrent periods. After the treatment, they reported
a 100% success rate without any recurrences; they did not
report any serious complications or infections. We thought
that it would be very difficult to apply repetitive doses of PI
or to place a percutaneous catheter in an experimental cyst
model of rats. In their experimental sclerotherapy studies,
Simsek et al. (31) applied a 95% ethanol instillation equal
to half of the amount of cyst fluid that they aspirated to

simple ovarian cysts for 5 min. Similarly, we determined
the 10% PI instillation time as 5 min.
Lim et al. (19) carried out sclerotherapy in 30 patients
with peritoneal inclusion cysts. After cyst aspiration, they
applied 10% PI as a sclerotherapy agent in 13 patients, and
they applied pure ethanol in 17 patients for sclerotherapy.
The maximum amount of sclerosing agent given was 100
mL and did not exceed one-third of the cyst fluid they
aspirated. In the long term, there was a 90% success rate
and secondary infections developed in only 2 patients who
did not use prophylactic antibiotics. At the end of the study,
it was reported that both PI and ethanol, as sclerosing
agents used for sclerotherapy, had similar successful effects
on cyst diameter.
Madeb et al. (32) suggested that treatment of
symptomatic simple renal cysts with PI sclerotherapy
was not indicated because of high recurrence rates. In
contrast, Harrach et al. (18) showed that sclerotherapy
with PI had high success rates in treatment of simple renal
cysts. In our study, while a significant decrease in ovarian
cyst diameter with 10% PI sclerotherapy was observed
when compared with the control (aspiration) group, no
complications such as macroscopic abdominal organ
damage or abdominal abscess formation were identified.
In this study, in histopathological examination of ovarian
tissue after instillation of 10% PI as the sclerosing agent, a
significant increase in fibrosis which was more prominent
in areas neighboring the cyst wall was found when
compared with the aspiration-only group. We think that
this histopathological effect is a result of PI damaging the
cyst wall and neighboring ovarian tissue. The increased
congestion in neighboring ovarian tissue supports our
findings. In the previous studies mentioned above, the
effects of PI sclerotherapy were investigated; however,
since they did not evaluate the histopathological effects of
PI sclerotherapy in cyst-adjacent areas, they did not give
any information about possible damage to neighboring
tissues.
The term ovarian reserve is defined as the number and
quality of follicles remaining in the ovaries at any given time
(33). In a prospective randomized study, it was shown that
cyst wall ablation may be a more appropriate method than

Table 3. Number of follicles count in both groups.
Groups

Primordial
follicle

Primary
follicle

Secondary
follicle

Tertiary
follicle

Corpus
luteum

After aspiration

10.25 ± 2.31

9.37 ± 3.24

4.25 ± 1.03

0.50 ± 0.53

11.50 ± 1.60

After 10% PI administration

9.25 ± 1.76

8.62 ± 2.61

3.87 ± 0.64

0.37 ± 0.51

10.87 ± 2.10

Values are given as mean ± standard deviation.
When compared to the postaspiration group (P > 0.05).

799

ATILGAN et al. / Turk J Med Sci
cystectomy in terms of preservation of ovarian function
(34). Recently, it has been shown that the application of
ethanol sclerotherapy after ultrasound-guided aspiration
reduces recurrence rates and does not adversely affect
reproductive outcomes (10,35,36). Although Atilgan et al.
(20) reported a significant decrease in ovarian cyst diameters
with 10 min of 10% ethanol sclerotherapy instillation in
an experimental rat model, they also found a significant
decrease in primordial, primary follicle count and ovarian
reserve in the ethanol-instilled group when compared with
the aspiration-only group. The same study showed that
10% ethanol application significantly increased fibrosis
in ovarian tissue. Simsek et al. (31) also showed that 95%
ethanol sclerotherapy applied for a 5-min period reduced
the size of ovarian cysts significantly; however, it did not
lead to a significant difference in the total follicle number
or fibrosis. With these two studies, it is understood that
the instillation time of a sclerotherapeutic agent such as
ethanol may be associated with increased ovarian damage.
As a result of the ovarian cyst sclerotherapy conducted
using trichloroacetic acid (TCA) by Artas et al. (37), it
was reported that a 5-min 5% TCA application led to a
significant decrease in the size of the cysts without causing
any significant decrease in ovarian reserve. They also
showed that in the group to which 5% TCA was applied,
there was a significant increase in fibrosis and congestion in
the adjacent ovarian tissue and parenchymal. In our study,
instillation of 5 min of 10% PI sclerotherapy resulted in an
increase in congestion and fibrosis in ovarian tissue, but
any decrease in ovarian reserve was not observed. Souza
et al. (38) reported that the increase in fibrosis could be
a compensatory mechanism which prevents the reduction

in ovarian reserve. This may explain the similar follicle
numbers determined in the groups despite the differences
in congestion and fibrosis. Thus, these results show that
ethanol sclerotherapy as administered by Atilgan et al. (20)
was more destructive than PI sclerotherapy, and PI can be
used more safely in simple ovarian cysts.
In an experimental pulmonary aspiration study, the
instillation of lung tissue with PI was shown to cause
atelectasis depending on the dose. Based on the primary
light and scanning electron microscopic findings in the
study, the scholars showed that edema had formed in the
pulmonary interstitium and that scar tissue formation
and alveolar rupture had occurred as a result of leukocyte
infiltration (39). In our study, congestion in ovarian stroma
and an increase in fibrosis was found in the group in which
PI was used. However, it was also seen that these effects
did not result in a significant decrease in the number of
follicles. This may be because the cyst wall, by acting like a
barrier, prevents the destructive effect of PI from reaching
distant tissue areas.
The fact that 10% PI sclerotherapy was applied to
the ovarian cysts for the first time in our study and that
ovarian histopathological changes were examined are
strengths of our study. On the other hand, our study was an
experimental study, the results obtained in animal models
cannot replicate human results due to the differences
between species, and the number of cases was limited,
which are limitations of the study.
In conclusion, sclerotherapy with 10% PI applied
into the ovarian cyst for 5 min significantly reduces cyst
diameter without a significant alteration in ovarian reserve.
Additionally, 10% PI is safe and well tolerated.
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